Natural immunity and protecting children
Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children […]
Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children […]
There are several theoretical reasons for implementing vaccine passports but now that none of these apply any longer in the UK it is difficult to see a rationale […]
Many factors influence decisions about vaccine use including many ‘unknowns’ and this raises questions about the wisdom of targeting young people and recommending boosters for everyone, explains Allyson […]
There was no evidence that mass testing stopped or prevented the transmission of covid-19, according to Professor Allyson Pollock, Clinical Professor of Public Health, Newcastle University. “Mass testing […]
As the coronavirus pandemic appears to be running out of steam it is important to review the lessons learned and move forward to ‘living with the virus’. IMI […]
90% of respondents supported revocation of the vaccine mandate, in a public consultation exercise carried out in February 2022. The UK Government has today (March 1st) published its […]
With low rates of disease flare and reactogenicity after vaccination, the study findings are reassuring for both patients and clinicians, according to Dr Caoilfhionn Connolly, Rheumatology Fellow at […]
A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the […]
Most people offered a COVID-19 vaccine in 2021 kept their appointment and rolled up their sleeves. However, as the year wore on, some countries struggled with vaccine hesitancy. […]
Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in the American Journal of Preventive Medicine. A […]
Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, […]
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]